Nashville TN, 37215
(919) 942-9903 office
Ph.D., Health Services Research
University of North Carolina at Chapel Hill
Master of Science in Pharmacy Administration, 1980
Bachelor of Science in Pharmacy with Honors, 1979
University of Illinois at Chicago
Center for Outcomes Research, Inc.
1996 - Present
· Provide outcomes related products and services to the health
Glaxo Wellcome, Inc.
1995 - 1996
Director, Pharmaceutical Outcomes
· Assessed the value of products and services in the Managed Care
1993 - 1995
Director, Outcomes Management
· Responsible for a team of researchers who apply economic and
outcomes evaluations with key customers in Managed Care.
· Developed disease management programs
Assistant Director, Allen &
· Responsible for all US A&H pharmacoeconomic studies
· Develop and implement QOL or economic strategy for each product
1991 - 1993
Assistant Director, Glaxo Research
· Conduct global economic and quality of life research
· Communicate findings to internal and external audiences
1990 - 1991
Senior Analyst, New Business and
University of North Carolina at Chapel Hill
1989 - 1990
Acting Chairman, Division of Pharmacy
1987 - 1989
Director, Pharmacy Policy Research
· Coordinated an interdisciplinary group of faculty members researching
health outcome and health policy issues
1983 - 1990
Assistant Professor, then Associate Professor with Tenure in 1990
1979 - 1983
Pharmacist in hospital and community
A Two-Stage Decision Analysis to Assess the Cost of 5-Aminosalicylic Acid Failure and the Economics of Balsalazide
Versus Mesalamine in the Treatment of Ulcerative Colitis. Managed Care Interface,
39-46, October 2006.
Weaver MB, Mackowiak JI, Solari PG. Triptan Therapy Impacts Health and Productivity. Journal of
Occupational and Environmental Medicine. J Occupation and Environmental Medicine,
Hogan P, Charles PD, Watts
MW, Massey JM, Miller T, Mackowiak JI. Severity and Impact of Xerostomia in Patients
Treated with Botulinum Toxin Type B for Cervical Dystonia: Observations on the Quality of Life of Patients with Xerostomia. Current Therapeutic Research, vol 65 no.2/161-171, March 2004.
Cole BF, Glantz MJ, Jaeckle KA, Chamberlain
MC, Mackowiak JI. Quality-of-Life-Adjusted Survival Comparison of Sustained-Release
Cytarabine versus Intrathecal Methotrexate for Treatment of Solid Tumor Neoplastic Meningitis.
Cancer, 97/12 3053-3060, June 2003.
Cox SE, Finn C, Stetler L, Mackowiak J, Kowalski
JW. Development of the Facial Lines Treatment Statisfaction (FTS) Questionnaire
and Initial Results for botulinum toxin type-A Treated Patients. Dermatologic
Surgery, 29:444-449, May 2003.
Wasserman T, Mackowiak JI, Brizel DM, Oster
W, Zhang J, Peeples PJ, Sauer R. Effect of Amifostine on Patient Assessed Clinical Benefit in Irradiated Head and Neck Cancer. International Journal of Radiation Oncology, 48(4) 1035-1039, Nov 2000.
Nash DB, Sullivan SD, Mackowiak J. Optimizing Quality of Care and Cost Effectiveness in Treating Allergic
Rhinitis in a Managed Care Setting. Am J Managed Care, 6, Jan 2000.
JI, Cost of heart failure to the health care system. Am J Managed Care, Jan;6(1 Suppl):s3-15; 2000.
Hansen JE, Mackowiak JI. Partnerships in Clinical Trials: Pharmaceutical Company and Managed Care Alliances.
Chapter 3 Economic Studies in MCO Settings. Parexel, 33-53,1998.
PJ, Wertheimer AI, Mackowiak JI, McGhan WF. Assessment and measurement of worker
productivity. J Research Pharm Economics, 8(3):33-46, 1997.
PJ, Wertheimer AI, Mackowiak JI, McGhan WF. Controversies in measuring and valuing
indirect costs of productivity foregone in a cost of illness evaluation. J Research
Pharm Economics, 8(3):23-32, 1997.
treatment of rhinitis: a managed care perspective. Am J Managed Care, 3 (Sup),
perspectives in the use of nasal steroids in the treatment of allergic rhinitis. Medical Interface (Sup), Aug 1997.
RF, Sclar DA, Nemec NL, Tarnai J, Mackowiak JI. Cost benefit of sumatriptan to
an employer. Journal of Occupational and Environmental Medicine, 39(7):652-7. Jul 1997.
D, Mackowiak JI. Point-of-service outcomes data and its effect on asthma treatment:
a salmeterol pilot study. Medical Interface, 10(2):118-124, Feb 1997.
RF, Sclar DA, Nemec NL, Tarnai J, Mackowiak JI. Cost-effectiveness of sumatriptan
in a managed care population. Am J of Managed Care, 3(1):117-122, Jan 1997.
JI. Managed Care Update: Will Measuring
and Reporting Outcomes Improve Health Care? Product Management Journal, 6(1):3-6,
CM, Schulz RM, Sclar DA, Kral KM, Mackowiak JI. A comparison of costs and efficacy
of intranasal fluticasone propionate and terfenadine tablets for seasonal allergic rhinitis.
Clinical Therapeutics, 18(2): 334-346, 1996.
Mahler DA, Mackowiak JI. Evaluation
of the short-form 36-itme questionnaire to measure health-related quality-of-life in patients with COPD. Chest. Jun;107(6):1585-9. 1995.
Sikirica V, Mackowiak J, Slaton T, Peterson J, Kaul S, Schein
J, Kahn J. Symptom Recurrence in Complicated Urinary Tract Infection (cUTI) or
Acute Pyelonephritis (AP): Levofloxacin 750mg vs. Ciprofloxacin 400/500mg. IDSA
43rd Annual Meeting, October 2007.
Gallant JE, Mackowiak JI, Dusek AC, Falcon RW, DeMasi R. Change
in Injection Attitudes and patient-Reported Outcomes Among Patients with Enfuvirtide (ENF) Experience. IAS Conference on HIV
Pathogenesis and Treatment, 3rd Meeting, July, 2005.
Kowalski JW, Sengelmann
RD, Waldorf HA, Fagien S, Fields N, Mackowiak JI. Development,
Validity, and Reliability of the Facial Lines Self-Confidence and Perception (FSP) Questionnaire. International Society for Quality of Life Research, 9th Annual Meeting, October 2002.
Kowalski JW, Mackowiak
JI, Cox SE, Finn C, Stetler L. Development, Validity, and Reliability of the Facial Lines Treatment Satisfaction
(FTS) Questionnaire. International Society for Quality of Life Research, 9th
Annual Meeting, October 2002.
Mackowiak J, Burris H, Stewart
M, Leavitt R. Validation of the Treatment Goals Questionnaire (TGQ): A New Instrument
to Assess Patient Benefit Following Treatment of Squamous Cell Carcinoma of the Head and Neck (HNSCC) with Intratumoral Cisplatin/Epinephrine
Injectable (CDDP/epi) gel. 37th Annual Meeting of the American Society
of Clinical Oncology, May 2001.
Mackowiak JI, Scott-Lennox J,
Lennox R, Wassermann T, Jackson S, Peeples P. Patient
Benefit Questionnaire (PBQ) for Xerostomia: Development and Validation Report. International
Society for Pharmacoeconomics and Outcomes Research, 4th Annual Meeting, May 1999.
Stempel DA, Mackowiak JI. Nasal Steroids Lead to Superior Outcomes in Rhinitis:
An Outcomes Monitoring Pilot Study in an HMO. 1996.
Bukstein D, Mackowiak J. Impact of Salmeterol on Health Status Scores (SF-36) in a Managed Care Environment. ATS Boston, May 1996.